Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin plus albendazole for lymphatic filariasis and onchocerciasis
PACTR202009704006025Phase 2Not yet recruiting
- Sponsor
- Kumasi Centre for Collaborative Research in Tropical Medicine
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rifampicin, albendazole and ivermectin in filariasis and onchocerciasis, sponsored by Kumasi Centre for Collaborative Research in Tropical Medicine. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
rifampicinalbendazoleivermectin
03
Conditions
filariasisonchocerciasis
Beyond the preview
Go deeper on PACTR202009704006025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009704006025.